Skip to main content

Global Point of Care (PoC) Imaging Devices Market to Reach $19.84 Billion by 2030

 According to a new market intelligence report by BIS Research titled “Global Point of Care imaging devices Market – Analysis & Forecast 2020-2030”, The global point of care (PoC) imaging devices market was valued at $8.66 billion in 2019 and is expected to reach $19.84 billion by the end of 2030, clocking a CAGR of 8.70%, during the forecast period.

BIS Research Report -  https://bisresearch.com/industry-report/point-of-care-imaging-devices-market.html

The diagnostic imaging technology ecosystem is facing significant changes in its market dynamics as new methodologies, technologies, and practices are currently being introduced in the market. The ecosystems are going through a period of amendments, driven by increasing demand for emerging technologies and its adoption in the healthcare sector. Several other factors ranging rising aging population to secure economic development in the emerging nations too are driving the growth of the PoC imaging devices market.

Request for a Sample:  https://bisresearch.com/requestsample?id=952&type=download

Some of the key drivers for the growth of the point of care (PoC) imaging devices market include growing need for more patient convenience, increased healthcare spending by countries to ramp up their healthcare infrastructure, and higher preference due to economic consideration.

PoC imaging devices are aimed at ensuring minimum inconvenience for patients. Thus, point of care imaging devices can be used at a patient’s bedside. The places include hospitals, ambulatory surgical centers, and also their homes. The use of handheld devices allows the scan to be performed at the patients’ homes, reducing or eliminating the need for hospital visits and is particularly useful for elderly patients. Furthermore, the use of handheld PoC enabled devices is now more relevant due to the ongoing COVID-19 pandemic.

The PoC imaging devices market comprises some of the leading players in the medical imaging ecosystem. These include Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Fujifilm Holdings Corporation, Samsung Electronics Co., Ltd., Canon Inc., and Digirad Corporation, among others. Additionally, there has been an increasing number of start-ups in the market which are gaining prominence or are expected to launch their product soon, including Butterfly Network, Inc., Hyperfine Research, and Perimeter Medical Imaging, among others.

 

The answers to the following key questions can be derived from this report:

·         What are the key regulations governing the Point-of-Care (PoC) Imaging devices market?

·         What are the key technological developments on which the current industry leaders are spending a major share of their R&D investment?

·         How is the role of PoC imaging devices expected to evolve in the future?

·         What level of impact will the COVID-19 crisis have on the market in terms of change in demand and the functioning of the supply chain?

·         Which leading players are holding a major share of the PoC imaging devices market?

·         What are the current business models and key strategies adopted by leading players, and how likely are those models to persist in future market scenarios?

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Lung Cancer Genomic Testing Market Industry Structure, Development, Demographics, Demands, Main Players, Innovative Technologies, and Opportunities Till 2031

  The shift of healthcare systems toward precision diagnostic and precision medicine will drive the adoption of lung cancer genomic testing facilitating informed treatment decision making and improving healthcare outcomes. Increasing recommendations by the international oncology societies for the use of genomic testing for lung cancer diagnosis provides major opportunities in the global lung cancer genomic testing market. The  lung cancer genomic testing medicine market  was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031. The growth in the global lung cancer genomic testing market is expected to be driven by increasing awareness and adoption of the lung cancer genomic testing market, recent launches of novel lung cancer genomic testing, and the expanding research in the field of lung cancer with an emphasis on pharmacogenomics and development of companion diagnostics. Im...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...